 Nicholas Behrendt
Concepts (155)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ultrasonography, Prenatal | 10 | 2024 | 295 | 1.590 |
Why?
| | Fetofetal Transfusion | 5 | 2025 | 26 | 1.440 |
Why?
| | Pregnancy, Twin | 3 | 2022 | 19 | 0.970 |
Why?
| | Meningomyelocele | 5 | 2022 | 62 | 0.730 |
Why?
| | Laser Coagulation | 2 | 2025 | 80 | 0.660 |
Why?
| | Cervix Uteri | 3 | 2022 | 50 | 0.630 |
Why?
| | Premature Birth | 4 | 2023 | 387 | 0.620 |
Why?
| | Pregnancy | 26 | 2026 | 7182 | 0.620 |
Why?
| | Hydrocephalus | 2 | 2022 | 111 | 0.610 |
Why?
| | Fetal Diseases | 3 | 2026 | 194 | 0.570 |
Why?
| | Fetal Development | 2 | 2021 | 298 | 0.550 |
Why?
| | Fetal Growth Retardation | 2 | 2025 | 592 | 0.480 |
Why?
| | Cervical Ripening | 2 | 2013 | 9 | 0.470 |
Why?
| | Lateral Ventricles | 1 | 2016 | 32 | 0.470 |
Why?
| | Fetoscopy | 3 | 2025 | 33 | 0.390 |
Why?
| | Pregnancy Complications | 4 | 2024 | 600 | 0.390 |
Why?
| | Placenta | 3 | 2016 | 784 | 0.380 |
Why?
| | Fetus | 3 | 2023 | 804 | 0.380 |
Why?
| | Uterine Hemorrhage | 1 | 2013 | 41 | 0.370 |
Why?
| | Gestational Age | 4 | 2026 | 987 | 0.370 |
Why?
| | Renal Insufficiency | 2 | 2026 | 172 | 0.360 |
Why?
| | Pregnancy Outcome | 4 | 2024 | 500 | 0.350 |
Why?
| | Sex Determination Analysis | 1 | 2011 | 10 | 0.340 |
Why?
| | Hernias, Diaphragmatic, Congenital | 2 | 2023 | 221 | 0.310 |
Why?
| | Magnetic Resonance Imaging | 3 | 2024 | 3892 | 0.300 |
Why?
| | Gastroschisis | 2 | 2020 | 33 | 0.300 |
Why?
| | Polycythemia | 2 | 2021 | 25 | 0.290 |
Why?
| | Twins, Monozygotic | 2 | 2021 | 133 | 0.270 |
Why?
| | Fetal Therapies | 2 | 2019 | 47 | 0.270 |
Why?
| | Comorbidity | 2 | 2024 | 1657 | 0.260 |
Why?
| | Body Mass Index | 2 | 2019 | 2437 | 0.260 |
Why?
| | Oligohydramnios | 1 | 2026 | 16 | 0.240 |
Why?
| | Amnion | 1 | 2026 | 31 | 0.240 |
Why?
| | Heart Rate, Fetal | 1 | 2026 | 31 | 0.240 |
Why?
| | Atrioventricular Block | 1 | 2026 | 44 | 0.230 |
Why?
| | Bradycardia | 1 | 2026 | 61 | 0.230 |
Why?
| | Female | 28 | 2026 | 78636 | 0.230 |
Why?
| | Micrognathism | 1 | 2024 | 19 | 0.210 |
Why?
| | Bartter Syndrome | 1 | 2023 | 7 | 0.200 |
Why?
| | Polyhydramnios | 1 | 2023 | 17 | 0.200 |
Why?
| | Hernia, Umbilical | 1 | 2023 | 21 | 0.200 |
Why?
| | Abortion, Spontaneous | 1 | 2023 | 118 | 0.190 |
Why?
| | Urethral Obstruction | 1 | 2022 | 7 | 0.180 |
Why?
| | Urethral Diseases | 1 | 2022 | 16 | 0.180 |
Why?
| | Uterine Cervical Diseases | 1 | 2022 | 6 | 0.180 |
Why?
| | Amniotic Fluid | 1 | 2022 | 79 | 0.180 |
Why?
| | Urinary Tract | 1 | 2022 | 47 | 0.180 |
Why?
| | Pregnancy Reduction, Multifetal | 1 | 2021 | 5 | 0.170 |
Why?
| | Prenatal Care | 3 | 2022 | 309 | 0.170 |
Why?
| | Twins, Dizygotic | 1 | 2021 | 108 | 0.160 |
Why?
| | Lupus Erythematosus, Systemic | 1 | 2023 | 238 | 0.160 |
Why?
| | Humans | 28 | 2026 | 145140 | 0.160 |
Why?
| | Fetal Death | 2 | 2023 | 57 | 0.160 |
Why?
| | Delivery, Obstetric | 1 | 2021 | 160 | 0.150 |
Why?
| | Retrospective Studies | 11 | 2024 | 17247 | 0.150 |
Why?
| | Lung Diseases | 1 | 2026 | 780 | 0.150 |
Why?
| | Anemia | 1 | 2021 | 190 | 0.150 |
Why?
| | Obstetric Surgical Procedures | 1 | 2019 | 6 | 0.150 |
Why?
| | Maternal Health | 1 | 2019 | 50 | 0.140 |
Why?
| | Tocolytic Agents | 1 | 2018 | 16 | 0.140 |
Why?
| | Kidney | 2 | 2026 | 1494 | 0.140 |
Why?
| | Infant, Newborn | 7 | 2026 | 6435 | 0.140 |
Why?
| | Indomethacin | 1 | 2018 | 76 | 0.140 |
Why?
| | Ductus Arteriosus | 1 | 2018 | 72 | 0.140 |
Why?
| | Maternal Exposure | 1 | 2020 | 188 | 0.140 |
Why?
| | Lung | 3 | 2026 | 4101 | 0.130 |
Why?
| | Hysterotomy | 1 | 2017 | 9 | 0.130 |
Why?
| | Prospective Studies | 5 | 2026 | 8035 | 0.130 |
Why?
| | Extracorporeal Membrane Oxygenation | 1 | 2022 | 387 | 0.130 |
Why?
| | Muscle Proteins | 2 | 2009 | 242 | 0.130 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2018 | 343 | 0.110 |
Why?
| | Risk Factors | 4 | 2025 | 10857 | 0.110 |
Why?
| | Pregnancy, Multiple | 1 | 2014 | 19 | 0.110 |
Why?
| | Twins | 1 | 2014 | 151 | 0.100 |
Why?
| | Abnormalities, Multiple | 1 | 2014 | 197 | 0.090 |
Why?
| | Adult | 10 | 2026 | 40665 | 0.090 |
Why?
| | Membrane Proteins | 2 | 2009 | 1163 | 0.090 |
Why?
| | Opioid-Related Disorders | 1 | 2020 | 600 | 0.090 |
Why?
| | Heart Defects, Congenital | 2 | 2024 | 904 | 0.090 |
Why?
| | Organ Size | 1 | 2013 | 459 | 0.090 |
Why?
| | Pregnancy Trimester, First | 1 | 2011 | 138 | 0.080 |
Why?
| | Hypertension, Pulmonary | 1 | 2022 | 1955 | 0.080 |
Why?
| | Trophoblasts | 2 | 2009 | 218 | 0.080 |
Why?
| | Infant | 4 | 2026 | 10060 | 0.070 |
Why?
| | Predictive Value of Tests | 2 | 2011 | 2115 | 0.070 |
Why?
| | Young Adult | 5 | 2020 | 14176 | 0.060 |
Why?
| | Pre-Eclampsia | 1 | 2009 | 206 | 0.060 |
Why?
| | Infusions, Parenteral | 1 | 2026 | 48 | 0.060 |
Why?
| | Isotonic Solutions | 1 | 2026 | 42 | 0.060 |
Why?
| | Umbilical Cord | 1 | 2026 | 92 | 0.060 |
Why?
| | Obesity | 1 | 2019 | 3097 | 0.060 |
Why?
| | Epinephrine | 1 | 2026 | 158 | 0.060 |
Why?
| | Treatment Outcome | 3 | 2026 | 11741 | 0.050 |
Why?
| | Jaw | 1 | 2024 | 27 | 0.050 |
Why?
| | Anatomic Landmarks | 1 | 2024 | 31 | 0.050 |
Why?
| | Cesarean Section | 1 | 2026 | 229 | 0.050 |
Why?
| | Lung Volume Measurements | 1 | 2023 | 46 | 0.050 |
Why?
| | Registries | 2 | 2025 | 2401 | 0.050 |
Why?
| | Hypoplastic Left Heart Syndrome | 1 | 2024 | 117 | 0.050 |
Why?
| | Follow-Up Studies | 2 | 2026 | 5411 | 0.050 |
Why?
| | Prenatal Diagnosis | 1 | 2024 | 196 | 0.050 |
Why?
| | Vesico-Ureteral Reflux | 1 | 2022 | 38 | 0.050 |
Why?
| | Morbidity | 1 | 2023 | 322 | 0.050 |
Why?
| | Renal Dialysis | 1 | 2026 | 466 | 0.040 |
Why?
| | Antigens, Neoplasm | 1 | 2023 | 271 | 0.040 |
Why?
| | Cerclage, Cervical | 1 | 2022 | 10 | 0.040 |
Why?
| | Urogenital Abnormalities | 1 | 2022 | 71 | 0.040 |
Why?
| | Congenital Abnormalities | 1 | 2022 | 109 | 0.040 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2023 | 425 | 0.040 |
Why?
| | Bupivacaine | 1 | 2020 | 40 | 0.040 |
Why?
| | Anesthetics, Local | 1 | 2020 | 104 | 0.040 |
Why?
| | Kidney Transplantation | 1 | 2026 | 710 | 0.040 |
Why?
| | Maternal Age | 1 | 2020 | 127 | 0.040 |
Why?
| | Dysferlin | 2 | 2009 | 5 | 0.040 |
Why?
| | Colorado | 2 | 2020 | 4538 | 0.040 |
Why?
| | Perinatal Death | 1 | 2019 | 26 | 0.040 |
Why?
| | Ventriculoperitoneal Shunt | 1 | 2019 | 44 | 0.040 |
Why?
| | Constriction | 1 | 2018 | 45 | 0.040 |
Why?
| | Tissue Distribution | 2 | 2009 | 335 | 0.030 |
Why?
| | Kidney Diseases | 1 | 2022 | 424 | 0.030 |
Why?
| | Cigarette Smoking | 1 | 2020 | 101 | 0.030 |
Why?
| | Case-Control Studies | 2 | 2020 | 3616 | 0.030 |
Why?
| | Calcium-Binding Proteins | 2 | 2009 | 221 | 0.030 |
Why?
| | Enteral Nutrition | 1 | 2019 | 217 | 0.030 |
Why?
| | Survival Rate | 1 | 2022 | 2087 | 0.030 |
Why?
| | Male | 3 | 2026 | 72664 | 0.030 |
Why?
| | Time Factors | 2 | 2019 | 7107 | 0.030 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2018 | 2026 | 0.030 |
Why?
| | Health Status | 1 | 2019 | 832 | 0.020 |
Why?
| | Analgesics, Opioid | 1 | 2020 | 1145 | 0.020 |
Why?
| | Term Birth | 1 | 2011 | 25 | 0.020 |
Why?
| | Uterine Contraction | 1 | 2011 | 17 | 0.020 |
Why?
| | Child, Preschool | 1 | 2026 | 11835 | 0.020 |
Why?
| | Pregnancy Trimester, Second | 1 | 2011 | 83 | 0.020 |
Why?
| | Reference Values | 1 | 2011 | 798 | 0.020 |
Why?
| | Risk Assessment | 1 | 2019 | 3740 | 0.020 |
Why?
| | HL-60 Cells | 1 | 2009 | 30 | 0.020 |
Why?
| | Cell Fusion | 1 | 2009 | 48 | 0.020 |
Why?
| | Colforsin | 1 | 2009 | 47 | 0.020 |
Why?
| | Monitoring, Physiologic | 1 | 2011 | 288 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2011 | 1300 | 0.020 |
Why?
| | Cell-Derived Microparticles | 1 | 2009 | 73 | 0.020 |
Why?
| | Microscopy, Fluorescence | 1 | 2009 | 408 | 0.020 |
Why?
| | Adolescent | 2 | 2022 | 22479 | 0.020 |
Why?
| | Down-Regulation | 1 | 2009 | 618 | 0.020 |
Why?
| | Postoperative Complications | 1 | 2019 | 2961 | 0.010 |
Why?
| | Cell Membrane | 1 | 2009 | 707 | 0.010 |
Why?
| | Phenotype | 1 | 2011 | 3138 | 0.010 |
Why?
| | Models, Biological | 1 | 2009 | 1763 | 0.010 |
Why?
| | Cells, Cultured | 1 | 2009 | 4142 | 0.010 |
Why?
| | RNA, Messenger | 1 | 2009 | 2803 | 0.010 |
Why?
| | Cohort Studies | 1 | 2011 | 5988 | 0.010 |
Why?
| | Gene Expression Regulation | 1 | 2009 | 2588 | 0.010 |
Why?
| | Cross-Sectional Studies | 1 | 2009 | 5886 | 0.010 |
Why?
| | Middle Aged | 1 | 2009 | 36126 | 0.000 |
Why?
|
|
Behrendt's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|